Biotech Values

[ed5150]

DEW and board members : GTCB, APPX and Albumin

I have been around GTC a while, but am not up to speed with all of the medical terms useed here on this fine board.

From what I have read, this APPX drug that just got approved is a new class of cancer drugs based around a protien called "Albumin". Now I might have this all wrong,so maybe somebody can take over and explain that.

Anyway, I think i have seen Dew and some other GTC longs state that other things in the pipeline are every bit as exciting os the one GTC has on the EMEA's docket currently...

I gues I am asking the board if this breakthrough for APPX can give GTC a lift ?

Lastly, would transgenically produced Albumin be appealing to a company like APPX..???

JUst a long who needs to understand the concept a little better...thx in advance guys..